Bank of New York Mellon’s BioCardia BCDA Stock Holding History

Bank of New York Mellon’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-839	Closed	-$33.6K	–	4349
2023 Q2	$33.6K	Sell	839 -6	-0.7%	-$185	﹤0.01%	4227
2023 Q1	$24.7K	Hold	845	–	–	﹤0.01%	4284
2022 Q4	$26.5K	Sell	845 -6	-0.7%	-$171	﹤0.01%	4321
2022 Q3	$25K	Hold	851	–	–	﹤0.01%	4418
2022 Q2	$19K	Sell	851 -6	-0.7%	-$144	﹤0.01%	4497
2022 Q1	$27K	Hold	857	–	–	﹤0.01%	4598
2021 Q4	$25K	Hold	857	–	–	﹤0.01%	4569
2021 Q3	$40K	Hold	857	–	–	﹤0.01%	4463
2021 Q2	$51K	Sell	857 -156	-15%	-$9.47K	﹤0.01%	4323
2021 Q1	$66K	Sell	1,013 -73	-7%	-$4.56K	﹤0.01%	4218
2020 Q4	$56K	Buy	+1,086	New	+$43.4K	﹤0.01%	4141

Other funds holding BCDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Bank of New York Mellon's BCDA Position: Q3 2023 in Review

Bank of New York Mellon sold out of BioCardia (BCDA) in Q3 2023, closing a stake of 839 shares — an estimated $33.6K sold.

Bank of New York Mellon first reported a position in BCDA in Q4 2020 and held it in 11 quarters. The position peaked at $66K in Q1 2021. 16 funds tracked by Wall St. Rank hold BCDA as of Q3 2023.

Bank of New York Mellon reported no remaining BioCardia position as of Q3 2023 after selling out during the quarter.
Bank of New York Mellon sold 839 BioCardia shares in Q3 2023, an estimated $33.6K.
Bank of New York Mellon first reported a position in BioCardia in Q4 2020 and held it in 11 quarters.
Bank of New York Mellon's BioCardia position peaked at $66K in Q1 2021.
16 funds tracked by Wall St. Rank held BioCardia as of Q3 2023.

Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.